Global Antibacterial Drugs Market Size, Share, Growth, Strategies, Segmentation and Forecast 2017 – 2025: Brisk Insights

PR Comments Off on Global Antibacterial Drugs Market Size, Share, Growth, Strategies, Segmentation and Forecast 2017 – 2025: Brisk Insights

According to a recently published report by Brisk Insight, the Global Antibacterial Drugs Market is expected to grow at the CAGR of 1.2% during 2017-2025. The global antibacterial drugs market is segmented on the basis of drug class and geography. The report on global antibacterial drugs market forecast 2017-2025 (by drug class and geography) provides a detailed overview and predictive analysis of the market.

Full report available Antibacterial Drugs market: Global Industry Size, Growth, Share and Forecast to 2025 report at

Market Insights

Antibacterials commonly known as antibiotics are commonly prescribed in modern medicine, with surge in bacterial infection. Bacterial infection is of major concern especially in cirrhosis patients since it is associated with mortality and morbidity. According to a study held by the WHO, cirrhotic patients associated urinary tract infection is mainly caused by the bacterial sepsis followed by spontaneous bacterial peritonitis (15 – 23%), respiratory tract infection (6 – 10%) and bacteremia (4-9%). High incidence of bacterial infections, vigorous research and development, rise in geriatric population, and high incidence of nosocomial infections are some of the factors leading to growth of antibacterial drugs market. This report on antibacterial drugs market includes various drugs used in market for treatment along with pipeline analysis of novel drugs coming up in future.

Browse here for all category Reports :

Scope of the report

1. Global Antibacterial drugs Market, by Drugs Type, 2015–2025 ($ Million)

1.1. Overview
1.2. Aminoglycosides
1.3. B-Lactams
1.3.1. Penicillins
1.3.2. Carbapenems
1.3.3. Cephalosporins
1.4. Tetracyclines
1.5. Sulfonamides
1.6. Quinolones
1.7. Macrolides
1.8. Phenicols
1.9. Miscellaneous Anti-bacterial Drugs
1.10. Pipeline Analysis
1.10.1. Projected sales of Phase III Drugs estimated till 2022 (US$ Mn) Solithromycin Actoxumab/bezlotoxumab (MK-3415A) Cadazolid Carbavance (meropenem/RPX7009) Eravacycline Omadacycline (PTK-0796) Others
1.11. Tabular Representation of Phase II and I Drugs

2. Global Antibacterial drugs Market, by Geography, 2015-2025 ($ Million)

2.1. North America (U.S. & Canada)
2.2. Europe (U.K., Germany & Rest of Europe)
2.3. Asia Pacific (China, Japan, and Rest of APAC)
2.4. Latin America (Brazil, Mexico and Rest of LATAM)
2.5. Middle East and Africa (UAE, Saudi Arabia, South Africa)

3. Profiles

3.1. Pfizer Inc.
3.2. Novartis AG
3.3. Merck & Co.
3.4. Astra Zeneca plc
3.5. Johnson & Johnson Limited
3.6. Abbott Laboratories
3.7. Eli Lilly and Company
3.8. Sanofi SA
3.9. Bristol-Myers Squibb Company
3.10. Bayer AG
3.11. GlaxoSmithKline plc
3.12. Others

Download Free Request Sample :

About Us :

Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies.
Working in a highly dynamic and multi-dimensional business makes decision making complex. Effective business decisions are a result of the synthesis of market information. Our Research and data analysis is an efficient and cost-effective way of providing robust market analysis and can yield highly valuable intelligence relating to consumers, competitors and markets.

Contact Us :

Jennifer Smith
Office 1094
109 Vernon House
Friar Lane
United Kingdom
Phone : +448081890034 (UK)
Email :
Website :



Back to Top